Clinical trials

  • sacituzumab govitecan for Metastatic solid tumors
  • Trametinib for Metastatic pancreatic adenocarcinoma
  • PEMBROLIZUMAB for HER2-positive gastroesophageal adenocarcinoma|HER2-positive gastric cancer
  • OMALIZUMAB for Severe allergic asthma|Allergic asthma
  • VARNIMCABTAGENE AUTOLEUCEL for Acute lymphoblastic leukemia
  • ATORVASTATIN for Coronary artery disease
  • CHORIOGONADOTROPIN ALFA for Infertility
  • Lenalidomide for Multiple myeloma|Newly diagnosed multiple myeloma
  • ARGIPRESSIN for Disseminated cancer
  • Empagliflozin for Type 2 diabetes
  • SARUPARIB for Prostate cancer | BRCA1/BRCA2-mutated high-risk localized/locally advanced prostate cancer
  • BRIGATINIB for Anaplastic large-cell lymphoma | Inflammatory myofibroblastic tumour | Other solid tumors